Showing posts with label Stimulants. Show all posts
Showing posts with label Stimulants. Show all posts
Wednesday, May 11, 2016
Thursday, April 14, 2016
Clinical characteristics of alcohol combined with other substance use disorders in an American Indian community sample
HIGHLIGHTS
- Multi-substance use disorder was more prevalent than single use disorder.
- Alcohol was the most common drug followed by stimulants and cannabis.
- Multi-substance use disorder was more severe and had greater co-morbidity.
BACKGROUND:
METHODS:
RESULTS:
CONCLUSIONS:
Purchase full article at: http://goo.gl/ma2Rmk
By: Gilder DA1, Stouffer GM1, Lau P1, Ehlers CL2.
- 1Molecular and Cellular Neuroscience Department, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
- 2Molecular and Cellular Neuroscience Department, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: cindye@scripps.edu.
- Drug Alcohol Depend. 2016 Apr 1;161:222-9. doi: 10.1016/j.drugalcdep.2016.02.006. Epub 2016 Feb 8.
More at: https://twitter.com/hiv insight
Tuesday, March 22, 2016
Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults
Background:
Energy drink use is
associated with increased risk behavior among adolescents and college students.
This study examined this relationship in a nationwide sample of young adults
and also examined relations between energy drink use and delay discounting.
Methods:
Participants were 874 U.S.
adults 18-28 years of age with past 30-day consumption of caffeine and alcohol.
Participants completed an online survey of energy drink use, drug use, sexual
activity, alcohol misuse (alcohol use disorders identification test [AUDIT]),
sensation seeking (four-item Brief Sensation Seeking Scale [BSSS-4]), and delay
discounting of monetary rewards and condom use.
Results:
Over one-third of
participants (n = 303) reported consuming energy drinks at least
once per week. Weekly energy drink users were more likely than less-than-weekly
energy drink users to report a recent history of risk behaviors, including
cigarette smoking (56% vs. 28%), illicit stimulant use (22% vs. 6%), and unprotected sex (63% vs. 45%). Covariate-adjusted analyses found
that weekly energy drink users did not have significantly higher BSSS-4 scores
(3.5 vs. 3.1), but they had higher mean AUDIT scores
(8.0 vs. 4.8), and they more steeply discounted
delayed monetary rewards. Although weekly energy drink users did not show
steeper discounting of delayed condom use, they showed a lower likelihood of
using a condom when one was immediately available.
Conclusions:
This study extends findings
that energy drink use is associated with risk behavior, and it is the first
study to show that energy drink use is associated with monetary delay
discounting.
Purchase full article at:
By: Meredith SE1, Sweeney MM2, Johnson PS2, Johnson MW2, Griffiths RR3.
- 1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut.
- 2Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine , Baltimore, Maryland.
- 3Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- J Caffeine Res. 2016 Mar 1;6(1):10-19.
More at: https://twitter.com/hiv insight
Friday, March 4, 2016
Public Opinions About Supervised Smoking Facilities for Crack Cocaine & Other Stimulants
BACKGROUND:
METHODS:
RESULTS:
CONCLUSIONS:
Purchase full article at: http://goo.gl/NQPMPC
By: Strike C1, Rotondi NK2, Watson TM3, Kolla G4, Bayoumi AM5,6,7,8.
- 1Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Canada. carol.strike@utoronto.ca.
- 2Musculoskeletal Health and Outcomes Research, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, Canada. nooshin.rotondi@gmail.com.
- 3Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Canada. tara.watson@utoronto.ca.
- 4Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Canada. gillian.kolla@utoronto.ca.
- 5Centre for Research on Innercity Health, Li Ka Shing Knowledge Institute, St. Michael's Hospital, 30 Bond Street, Toronto, Canada. ahmed.bayoumi@utoronto.ca.
- 6Department of Medicine, University of Toronto, 1 King's College Circle, Toronto, Canada. ahmed.bayoumi@utoronto.ca.
- 7Institute of Health Policy, Management, and Evaluation, University of Toronto, 155 College Street, Toronto, Canada. ahmed.bayoumi@utoronto.ca.
- 8Division of General Internal Medicine, St. Michael's Hospital, 30 Bond Street, Toronto, Canada. ahmed.bayoumi@utoronto.ca.
- Subst Abuse Treat Prev Policy. 2016 Feb 9;11(1):8. doi: 10.1186/s13011-016-0052-7.
More at: https://twitter.com/hiv insight
Wednesday, February 3, 2016
Self-Reported Sexually Transmitted Infections & Sexual Risk Behaviors in the U.S. Military: How Sex Influences Risk
BACKGROUND:
METHODS:
RESULTS:
CONCLUSIONS:
Difference in behaviors of sexually active unmarried service members by gender, 2008 HRBS dataset (n=10,250)
| Characteristics | Men (n=6,822) | Women (n=3,428) | p-value | ||||
|---|---|---|---|---|---|---|---|
| n | % | 95% CI | n | % | 95% CI | ||
| Alcohol and Drug Use | |||||||
| Binge drinking | 4101 | 61.1 | (57.1, 65.2)^ | 1290 | 38.1 | (35.1, 41.2) | <.001*** |
| Any illicit substance use, past 12 mo. | 588 | 10.3 | (8.5, 12.1) | 215 | 6.6 | (4.2, 9.1) | <.001*** |
| Marijuana | 466 | 8.3 | (6.4, 10.1) | 178 | 5.5 | (3.1, 7.9) | 0.007** |
| Cocaine | 210 | 3.6 | (2.6, 4.6) | 66 | 2.0 | (1.0, 3.0) | 0.014* |
| Ecstasy | 178 | 3.2 | (2.5, 3.9) | 66 | 2.3 | (1.3, 3.3) | 0.055 |
| Methamphetamine | 102 | 1.7 | (1.2, 2.2) | 30 | 0.9 | (0.5, 1.2) | <.001*** |
| Heroin | 89 | 1.4 | (1.0, 1.8)^ | 20 | 0.5 | (0.1, 0.9) | 0.004** |
| Other illicit substance | 297 | 5.1 | (4.3, 5.8)^ | 70 | 2.3 | (1.3, 3.3) | <.001*** |
| Any prescription drug use for non-medical purpose, past 12 mo. | 1291 | 20.4 | (18.7, 22.1) | 771 | 23.8 | (21.2, 26.3) | 0.006** |
| Stimulants | 188 | 3.3 | (2.7, 3.9) | 108 | 3.3 | (2.4, 4.1) | 0.993 |
| Tranquilizers | 416 | 6.8 | (6.0, 7.7) | 275 | 8.4 | (6.9, 10.0) | 0.032* |
| Sedatives | 219 | 3.7 | (3.0, 4.4) | 142 | 4.4 | (3.1, 5.7) | 0.346 |
| Painkillers | 1199 | 18.9 | (17.2, 20.5) | 717 | 22.2 | (19.6, 24.9) | 0.009** |
| Steroids | 156 | 2.6 | (2.1, 3.0) | 55 | 2.0 | (1.3, 2.8) | 0.248 |
| Sexual Risks | |||||||
| Condom use at last sex | 2685 | 43.0 | (40.9, 45.1)^ | 1005 | 32.1 | (28.8, 35.4) | <.001*** |
| Main partner at last sex | 4404 | 62.9 | (61.1, 64.6) | 2839 | 82.5 | (80.2, 84.8)^ | <.001*** |
| No. of sex partners, past 12 mo. | <.001*** | ||||||
| 5+ | 1654 | 25.2 | (23.5, 26.8)^ | 339 | 9.3 | (7.8, 10.8) | |
| 2-4 | 2705 | 39.8 | (38.4, 41.2) | 1278 | 38.4 | (35.2, 41.6) | |
| 1 | 2463 | 35.0 | (34.0, 36.1) | 1811 | 52.3 | (48.5, 56.0)^ | |
| No. of NEW sex partners, past 12 mo. | <.001*** | ||||||
| 2+ | 3403 | 51.3 | (50.2, 52.3)^ | 1069 | 30.7 | (27.3, 34.1) | |
| 1 | 1574 | 23.4 | (22.5, 24.3) | 965 | 31.3 | (29.4, 33.3)^ | |
| None | 1799 | 25.3 | (24.3, 26.4) | 1383 | 37.9 | (35.2, 40.7)^ | |
| Unwanted sexual contact | 196 | 2.9 | (2.3, 3.6) | 515 | 14.2 | (12.0, 16.4)^ | <.001*** |
| STI, past 12 mo. | 273 | 4.2 | (3.5, 4.8) | 217 | 6.9 | (5.7, 8.1)^ | <.001*** |
| Mental Health Indicators | |||||||
| Depression | 1567 | 24.8 | (23.2, 26.4) | 977 | 28.4 | (26.6, 30.2)^ | 0.002** |
| Anxiety | 871 | 13.9 | (12.2, 15.5) | 678 | 20.3 | (17.6, 22.9)^ | <.001*** |
| PTSD | 762 | 12.2 | (10.7, 13.7) | 467 | 13.9 | (12.4, 15.4) | 0.097 |
| Overall stress | <.001*** | ||||||
| Low | 3370 | 48.9 | (46.1, 51.6)^ | 1421 | 40.9 | (37.7, 44.1) | |
| Moderate | 1821 | 27.0 | (25.6, 28.4) | 1079 | 31.6 | (29.5, 33.7)^ | |
| High | 1571 | 24.1 | (21.7, 26.5) | 904 | 27.5 | (25.1, 29.8) | |
| High military-related stress | 1765 | 27.1 | (25.1, 29.1) | 1068 | 31.4 | (28.6, 34.2) | <.001*** |
| High family or personal-life stress | 1256 | 19.2 | (17.7, 20.6) | 815 | 22.9 | (20.9, 25.0)^ | <.001*** |
| Any gender-Related stress | -- | -- | -- | 2887 | 86.0 | (83.9, 88.1) | -- |
| Psychological distress | 1053 | 16.6 | (15.1, 18.1) | 782 | 22.2 | (19.3, 25.1)^ | <.001*** |
| Suicide ideation | 341 | 5.7 | (4.9, 6.4) | 193 | 5.4 | (3.9, 7.0) | 0.797 |
| Suicide attempt | 85 | 1.4 | (1.0, 1.8) | 79 | 2.2 | (1.4, 3.0) | 0.048* |
^95% confidence intervals of the prevalence estimate do not overlap
*p<0.05;
**p<0.01;
***p<0.001; P-values derived by Rao-Scott Chi-Square Test Percentages shown are weighted; n’s are unweighted
Full article at: http://goo.gl/O7oZ0n
By: Stahlman S1, Javanbakht M, Cochran S, Hamilton AB, Shoptaw S, Gorbach PM.
- 1From the *Department of Epidemiology, Fielding School of Public Health, †Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, and ‡Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA.
- Sex Transm Dis. 2014 Jun;41(6):359-64. doi: 10.1097/OLQ.0000000000000133.
More at: https://twitter.com/hiv insight
Subscribe to:
Posts (Atom)








































